TCMBANKIN000281 |
Myricadiol |
AC1NSYWT; isomyricadiol; myricadiol; (3S,14bR)-8a-(hydroxymethyl)-4,4,6a,6a,11,11,14b-heptamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-ol |
C30H50O2 |
442.72 |
CC1(CCC2(CC=C3C4(CCC5C(C(CCC5(C4CCC3(C2C1)C)C)O)(C)C)C)CO)C |
TCMBANKIN010814 |
heraclenol |
heraclenol |
C16H16O6 |
304.29 g/mol |
CC(C)(C(COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2)O)O |
TCMBANKIN012614 |
rutamarin |
|
C21H24O5 |
356.4 g/mol |
CC(=O)OC(C)(C)C1CC2=C(O1)C=C3C(=C2)C=C(C(=O)O3)C(C)(C)C=C |
TCMBANKIN015172 |
Matsukaze lactone |
MLS002472930; 7-methoxy-8-(7-methoxy-2-oxo-6-chromenyl)-2-chromenone; CHEMBL1877565; matsukazelactone; 7-methoxy-8-(7-methoxy-2-oxochromen-6-yl)chromen-2-one; 7-methoxy-8-(7-methoxy-2-oxo-chromen-6-yl)chromen-2-one; matsukaze lactone; SMR001397040; 8-(2-keto-7-methoxy-chromen-6-yl)-7-methoxy-coumarin; AC1NSXWA; HMS2268O14 |
C20H14O6 |
350.3 g/mol |
COC1=C(C2=C(C=C1)C=CC(=O)O2)C3=C(C=C4C(=C3)C=CC(=O)O4)OC |
TCMBANKIN020979 |
dictysine |
|
C21H33NO3 |
347.5 g/mol |
CC12CCCC34C1CC(C3N(C2)C)C56C4CC(CC5)C(C6O)(CO)O |
TCMBANKIN022674 |
(e)-7-hydroxy-6-(3-hydroxy-methyl-1-butenyl)-2h-1-benzopyran-2-one |
|
C14H14O4 |
|
CC(C)(C=CC1=C(C=C2C(=C1)C=CC(=O)O2)O)O |
TCMBANKIN026185 |
5,8-Dimethylbellidifolin |
Xanthen-9-one, 1-hydroxy-3,5,8-trimethoxy-; 1-Hydroxy-3,5,8-trimethoxyxanthen-9-one; 1-hydroxy-3,5,8-trimethoxy-9-xanthenone; 1-hydroxy-3,5,8-trimethoxy-xanthen-9-one; 49599-09-9; 1-hydroxy-3,5,8-trimethoxy-xanthone; BRN 0315646 |
C16H14O6 |
302.28 |
COC1=C2C(=C(C=C1)OC)OC3=CC(=CC(=C3C2=O)O)OC |
TCMBANKIN028076 |
rutarin |
|
C20H24O10 |
424.4 g/mol |
CC(C)(C1CC2=C(O1)C(=C3C(=C2)C=CC(=O)O3)OC4C(C(C(C(O4)CO)O)O)O)O |
TCMBANKIN035830 |
justicidin b |
|
C21H16O6 |
364.3 g/mol |
COC1=CC2=CC3=C(C(=C2C=C1OC)C4=CC5=C(C=C4)OCO5)C(=O)OC3 |
TCMBANKIN037331 |
Xanthyletin |
xanthyletin |
|
228.24 g/mol |
|
TCMBANKIN037486 |
Jayantinin |
|
|
|
|
TCMBANKIN038440 |
3-(1,1-dimethylallyl)-xanthyletin |
|
C19H20O3 |
|
CC1(C=CC2=C(O1)C=C3C(=C2)C=C(C(=O)O3)C(C)(C)C=C)C |
TCMBANKIN041411 |
Murralongin |
|
|
258.27 g/mol |
|
TCMBANKIN041880 |
albiflorin-1 |
|
C17H18O6 |
|
|
TCMBANKIN043185 |
Bhubaneswin |
|
|
336.3 g/mol |
|
TCMBANKIN044925 |
6-(trans-1-Buten-3-oxy)-7-methoxycoumarin |
|
|
|
|
TCMBANKIN045542 |
luvangetin |
|
C15H14O4 |
258.27 g/mol |
CC1(C=CC2=C(O1)C(=C3C(=C2)C=CC(=O)O3)OC)C |
TCMBANKIN046596 |
micropubescin |
|
C15H14O4 |
258.27 g/mol |
CC(=C)CC(=O)C1=C(C=CC2=C1OC(=O)C=C2)OC |
TCMBANKIN048438 |
boennin |
|
C19H12O8 |
368.3 g/mol |
COC1=C(C2=C(C=C1)C=CC(=O)O2)OC3=C(C=C(C4=C3OC(=O)C=C4)O)O |
TCMBANKIN048758 |
Angelical |
|
|
204.18 |
|
TCMBANKIN049007 |
albiflorin-3 |
|
C16H18O5 |
290.31 g/mol |
CC(=C)C(C(C1=C(C=CC2=C1OC(=O)C=C2)OC)OC)O |
TCMBANKIN049115 |
dehydrogeijerin |
|
C15H14O4 |
258.27 g/mol |
CC(=CC(=O)C1=C(C=C2C(=C1)C=CC(=O)O2)OC)C |
TCMBANKIN050127 |
Nodakenetin acetate |
|
|
|
|
TCMBANKIN058677 |
albiflorin-2 |
albiflorin-3; murracarpin |
C16H18O5 |
290.31 g/mol |
CC(=C)C(C(C1=C(C=CC2=C1OC(=O)C=C2)OC)OC)O |
TCMBANKIN058904 |
(z)-7-hydroxy-6-(3-hydroxy-methyl-1-butenyl)-2h-1-benzopyran-2-one |
(r)-(+)-7-hydroxy-8-(2-hydroxy-3-methyl-3-butenyl)-2h-1-benzopyran-2-one |
C14H14O4 |
|
CC(=CCOC1=C(C=C2C=CC(=O)OC2=C1)O)C |
TCMBANKIN061525 |
justicidin c;neojusticin b |
|
C22H18O7 |
394.4 g/mol |
COC1=C(C=C2C(=C1)C(=C3COC(=O)C3=C2OC)C4=CC5=C(C=C4)OCO5)OC |
TCMBANKIN061639 |
xenognosin a |
xenognosin |
C16H16O3 |
256.3 g/mol |
COC1=C(C=CC(=C1)O)CC=CC2=CC=C(C=C2)O |
TCMBANKIN061695 |
Majudin |
Spectrum2_000534; 5-19-06-00004 (Beilstein Handbook Reference); 4-methoxyfuro[3,2-g]chromen-7-one; Spectrum3_000663; KBio3_001545; CCRIS 4348; KBioGR_002055; 4-methoxy-7-furo[3,2-g]chromenone; DivK1c_000529; NCGC00091582-01; 7H-Furo[3,2-g][1]benzopyran-7-one, 4-methoxy-; KBio2_001274; TNP00299; NINDS_000529; Bergapten; Spectrum5_000155; EINECS 207-604-5; KBio1_000529; 4-Methoxy-7H-furo(3,2-g)(1)benzopyran-7-one; KBioSS_001274; ACon0_000984; AIDS031096; 4-methoxy-7H-furo[3,2-g]chromen-7-one; HSDB 3466; 5-Methoxypsoralen; Spectrum_000794; KBio2_003842; BSPBio_002325; MEGxp0_000990; 65320_FLUKA; BRN 0019560; 5-Mop; 6-Hydroxy-4-methoxy-5-benzofuranacrylic acid, gamma-lactone; NCGC00091582-02; Bergaptene; 5-Methoxy psoralen; NCI60_042121; 5-Methoxy-6,7-furanocoumarin; KBio2_006410; 4-Methoxy-furo[3,2-g]chromen-7-one; IDI1_000529; Bergapten(e); BAS 00674110; ACon1_001979; SPBio_000547; 5-Methoxypsoralen with ultraviolet A therapy; BERGAPTAN; Psoraderm; SDCCGMLS-0066492.P001; NSC95437; 7H-Furo(3,2-g)(1)benzopyran-7-one, 4-methoxy-; ST057259; ZINC00057731; InChI=1/C12H8O4/c1-14-12-7-2-3-11(13)16-10(7)6-9-8(12)4-5-15-9/h2-6H,1H; C01557; Heraclin; NCGC00091582-03; 4-Methoxyfuro[3,2-g]benzopyrane-7-one; 275727_ALDRICH; Spectrum4_001478; SPECTRUM300546; O-Methylbergaptol; 5-Methoxyfuranocoumarin; NSC 95437; NCGC00017357-01; AIDS-031096; 484-20-8; Oprea1_562364; 5-methoxypsoralen; bergapten;5-19-06-00004 (Beilstein Handbook Reference); AB00052148_06; V0122; DivK1c_000529; NCGC00259906-01; KBio2_001274; EINECS 207-604-5; Geralen; SR-05000002173; KBio1_000529; KBioSS_001274; Majudin; 4-Methoxy-7H-furo[3,2-g]chromen-7-one #; 4-Methoxy-7H-furo[3,2-g]chromen-7-one; HMS501K11; 5-Methoxypsoralen, 99%; SMR000112435; NCGC00017357-03; NCGC00017357-07; CAS-484-20-8; B2840; AK134854; KS-00000GSD; TR-017690; Bergapten(e); NCGC00017357-04; BAS 00674110; CC-24574; C-11626; BERGAPTAN; Psoraderm; D07521; SDCCGMLS-0066492.P001; BRD-K12968785-001-03-4; MLS002207272; 5-Methoxypsoralen (Bergapten); InChI=1/C12H8O4/c1-14-12-7-2-3-11(13)16-10(7)6-9-8(12)4-5-15-9/h2-6H,1H; Bergaptene (DCF); 5-methoxy-psoralen; Pentaderm (TN); SPECTRUM300546; HY-N0370; ANW-42611; 5-Methoxypsoralen (obsol.); 5-Methoxy psoralen; KBioGR_002055; Oprea1_562364; Tox21_303255; NCGC00178705-02; Q-100536; Spectrum3_000663; BRD-K12968785-001-02-6; 4-methoxy-7H-furo[3,2-g][1]benzopyran-7-one; NCGC00017357-08; 7H-Furo[3,2-g][1]benzopyran-7-one, 4-methoxy-; ZINC57731; TNP00299; Bergapten; BDBM50067880; Spectrum5_000155; NSC755877; 4-Methoxy-7H-furo(3,2-g)(1)benzopyran-7-one; AB00052148_07; DS-2970; Spectrum_000794; KBio2_003842; 5-methoxy-2H-furo[3,2-g]chromen-2-one; BRN 0019560; NCGC00178705-01; 5-Mop; UNII-4FVK84C92X; M-9412; NCGC00091582-02; HMS2268M24; CHEBI:18293; CS-2234; 5 methoxypsoralen; 5-methoxypsoralen ; 5-Methoxy-6,7-furanocoumarin; KBio2_006410; NCGC00017357-05; SR-05000002173-5; CCG-39946; 5-Methoxypsoralen with ultraviolet A therapy; DSSTox_CID_5560; NSC95437; CJ-00484; 7H-Furo(3,2-g)(1)benzopyran-7-one, 4-methoxy-; ST057259; 6-Hydroxy-4-methoxy-5-benzofuranacrylic acid, .gamma.-lactone; NCGC00017357-02; N1304; AC1Q47BC; NCGC00091582-03; SBI-0051583.P002; 4-Methoxy-7H-furo[3,2-g]benzopyran-7-one; NSC 95437; 5-methoxyfurano[3,2-g]chromen-2-one; bergaptene; 484-20-8; CTK3J2399; s4239; Spectrum2_000534; Pentaderm; 4FVK84C92X; KBio3_001545; HMS3652F19; ST2411501; NINDS_000529; STK333038; MCULE-7768334865; NCGC00017357-06; HSDB 3466; 5-Methoxypsoralen; BSPBio_002325; CB-1199; 6-Hydroxy-4-methoxy-5-benzofuranacrylic acid, gamma-lactone; BGEBZHIAGXMEMV-UHFFFAOYSA-N; I14-13388; MFCD00010272; bmse000758; IDI1_000529; AB0019675; DB12216; 4-Methoxyfuro[3,2-g]benzopyrane-7-one; 4-Methoxyfuro[3,2-g]benzopyran-7-one; O-Methylbergaptol; 484B208; RTR-017690; NCGC00091582-04; SC-46077; AKOS000276715; SR-05000002173-3; CCRIS 4348; DSSTox_GSID_25560; 4-methoxyfuro[3,2-g]chromen-7-one; ZB002242; DTXSID1025560; NSC-755877; NCGC00091582-01; 5-methoxypsoralene; AX8014410; A827532; AJ-09777; ACon0_000984; Tox21_202357; HMS1923G13; FT-0603416; MEGxp0_000990; AC1L1DHU; MolPort-000-880-879; NSC-95437; 4CN-0945; NCI60_042121; BG01521510; 4-Methoxy-furo[3,2-g]chromen-7-one; NCGC00256998-01; AC-20189; CHEMBL24171; SPBio_000547; ACon1_001979; DSSTox_RID_77830; 7H-Furo[3, 4-methoxy-; SR-05000002173-2; Bergapten, analytical standard; SCHEMBL50066; 4-methoxy-7-furo[3,2-g][1]benzopyranone; Heraclin; C01557; Bio-0829; Spectrum4_001478; LS-1292; D0QR5G; Pharmakon1600-00300546; 5-Methoxyfuranocoumarin; MLS002454380; NCGC00017357-01; AN-9448 |
C12H8O4 |
216.19 g/mol |
COC1=C2C=CC(=O)OC2=CC3=C1C=CO3 |
TCMBANKIN061698 |
Dictamine |
Spectrum3_000101; SPECTRUM100541; C10660; Furo(2,3-b)quinoline, 4-methoxy-; dictamnine; Furo[2,3-b]quinoline, 4-methoxy-; KBio2_006213; NCGC00095429-01; SDCCGMLS-0066336.P001; Dictamnine; CCRIS 1583; Spectrum2_000349; Oprea1_294767; KBio3_000802; 484-29-7; Spectrum4_001383; dictamine ; Oprea1_134081; DivK1c_006140; SPBio_000417; SpecPlus_000044; 4-methoxyfuro[2,3-b]quinoline; Spectrum_000597; KBio2_003645; KBioSS_001077; BSPBio_001682; KBio2_001077; dictamine; KBioGR_001706; KBio1_001084; Spectrum5_000086; 4-27-00-02030 (Beilstein Handbook Reference); BRN 0176932;Spectrum3_000101; SPECTRUM100541; AC1L2901; LS-70926; C10660; Furo(2,3-b)quinoline, 4-methoxy-; DTXSID0041012; Furo[2,3-b]quinoline, 4-methoxy-; MCULE-6817939774; MolPort-003-665-620; C12H9NO2; AM-331/20711025; KBio2_006213; CTK4J0807; NCGC00095429-01; AKOS006274709; SDCCGMLS-0066336.P001; Dictamnine; Furo[2,3-b]quinoline,4-methoxy-; NCGC00095429-02; CCRIS 1583; FT-0686595; Spectrum2_000349; Oprea1_294767; V0176; KBio3_000802; 4-Methoxyfuro[2,3-b]quinoline #; 484-29-7; Spectrum4_001383; BRD-K29178788-001-01-2; 4-Methoxyfuro[2,3-b]quinoline; CCG-38624; Oprea1_134081; DivK1c_006140; SR-05000002442; Q-100537; WIONIXOBNMDJFJ-UHFFFAOYSA-N; SPBio_000417; SR-05000002442-1; SpecPlus_000044; CS-3267; Spectrum_000597; N2224; 484D297; CHEBI:4512; KBio2_003645; BSPBio_001682; KBioSS_001077; HQZ3798D0A; Diktaminin; SCHEMBL1760700; Dictamine; CHEMBL22533; VU0243862-3; HY-N0849; KBio2_001077; KBioGR_001706; UNII-HQZ3798D0A; HMS3561L11; AN-45222; 4-Methoxy-furo[2,3-b]quinoline; ZINC265517; AC1Q4FDA; KBio1_001084; Spectrum5_000086; 4-27-00-02030 (Beilstein Handbook Reference); BRN 0176932 |
C12H9NO2 |
199.21 |
COC1=C2C=COC2=NC3=CC=CC=C31 |
TCMBANKIN020979 |
dictysine |
|
C21H33NO3 |
347.5 g/mol |
CC12CCCC34C1CC(C3N(C2)C)C56C4CC(CC5)C(C6O)(CO)O |
TCMBANKIN022674 |
(e)-7-hydroxy-6-(3-hydroxy-methyl-1-butenyl)-2h-1-benzopyran-2-one |
|
C14H14O4 |
|
CC(C)(C=CC1=C(C=C2C(=C1)C=CC(=O)O2)O)O |
TCMBANKIN058904 |
(z)-7-hydroxy-6-(3-hydroxy-methyl-1-butenyl)-2h-1-benzopyran-2-one |
(r)-(+)-7-hydroxy-8-(2-hydroxy-3-methyl-3-butenyl)-2h-1-benzopyran-2-one |
C14H14O4 |
|
CC(=CCOC1=C(C=C2C=CC(=O)OC2=C1)O)C |
TCMBANKIN061698 |
Dictamine |
Spectrum3_000101; SPECTRUM100541; C10660; Furo(2,3-b)quinoline, 4-methoxy-; dictamnine; Furo[2,3-b]quinoline, 4-methoxy-; KBio2_006213; NCGC00095429-01; SDCCGMLS-0066336.P001; Dictamnine; CCRIS 1583; Spectrum2_000349; Oprea1_294767; KBio3_000802; 484-29-7; Spectrum4_001383; dictamine ; Oprea1_134081; DivK1c_006140; SPBio_000417; SpecPlus_000044; 4-methoxyfuro[2,3-b]quinoline; Spectrum_000597; KBio2_003645; KBioSS_001077; BSPBio_001682; KBio2_001077; dictamine; KBioGR_001706; KBio1_001084; Spectrum5_000086; 4-27-00-02030 (Beilstein Handbook Reference); BRN 0176932;Spectrum3_000101; SPECTRUM100541; AC1L2901; LS-70926; C10660; Furo(2,3-b)quinoline, 4-methoxy-; DTXSID0041012; Furo[2,3-b]quinoline, 4-methoxy-; MCULE-6817939774; MolPort-003-665-620; C12H9NO2; AM-331/20711025; KBio2_006213; CTK4J0807; NCGC00095429-01; AKOS006274709; SDCCGMLS-0066336.P001; Dictamnine; Furo[2,3-b]quinoline,4-methoxy-; NCGC00095429-02; CCRIS 1583; FT-0686595; Spectrum2_000349; Oprea1_294767; V0176; KBio3_000802; 4-Methoxyfuro[2,3-b]quinoline #; 484-29-7; Spectrum4_001383; BRD-K29178788-001-01-2; 4-Methoxyfuro[2,3-b]quinoline; CCG-38624; Oprea1_134081; DivK1c_006140; SR-05000002442; Q-100537; WIONIXOBNMDJFJ-UHFFFAOYSA-N; SPBio_000417; SR-05000002442-1; SpecPlus_000044; CS-3267; Spectrum_000597; N2224; 484D297; CHEBI:4512; KBio2_003645; BSPBio_001682; KBioSS_001077; HQZ3798D0A; Diktaminin; SCHEMBL1760700; Dictamine; CHEMBL22533; VU0243862-3; HY-N0849; KBio2_001077; KBioGR_001706; UNII-HQZ3798D0A; HMS3561L11; AN-45222; 4-Methoxy-furo[2,3-b]quinoline; ZINC265517; AC1Q4FDA; KBio1_001084; Spectrum5_000086; 4-27-00-02030 (Beilstein Handbook Reference); BRN 0176932 |
C12H9NO2 |
199.21 |
COC1=C2C=COC2=NC3=CC=CC=C31 |